Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028 OverviewBellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028 Profit Margin
Profitability ratio analysis for BLACR.
Quarterly Profit Margin
-716.27%
↑ 52.14% YoY
As of Mar 2026
Annual Profit Margin (TTM)
301.52%
↑ 116.70% YoY
Trailing 12 months ending Mar 2026
Average Profit Margin (Comparison Companies)
Profit Margin History
Profit Margin Comparison
Annual Profit Margin Growth Rate (%)